Member Info for whimax

Thanks Y-Alam for clarification.

Yes Greend100, I’ve said a couple of times, that where I expect us to be significantly higher than this come 31st (and i still do) the lower the price is at that point, the smaller any sell off will be and the easier it will be for the Management to “shore up” (if that’s the right words) the TILS share price with other news.
I also agree that AccuStem will never list as it will be sold before that happens. Anyone that is holding off buying these because of a delay between Demerger date and list date is mad imo.

StrictlyInc, it’s not nothing, it’s equivalent to the total of the last 3 days traded on the Nasdaq.

Agreed TrumptonTown. Short interest is still 650k shares and they will most certainly NOT want to caught on the wrong side of a scramble for shares when it starts. They will have to start closing soon imo.
See here on the right hand side of the screen.
https://www.barrons.com/quote/stock/us/xnas/tlsa

I understand this is hard to watch (it’s the same for all of us) but this is not uncommon when there’s big rewards up for grabs.
Ignore the irrelevance, the nonsense and the noise, and focus on the end game.

Feels like a push down on Nasdaq to allow Shorts to close imo. No way this drops like on the volume we’re seeing. Bounce coming imo

Welcome Professional.

It all boils down to timing of news (as you, and others have stated). I don’t invest/trade on technicals, so you are better placed to guess at any downside than me from that perspective, but having listened to the recent Management Presentation and taken into account the recent resource upgrades etc, our MCap of £13m seems very cheap (FinnCap’s recent risked net asset value of £120m for Anchois alone would equal about 30p per share).

You can currently buy at 3.5p(ish) and if timings/updates slip you may be able to get in nearer to 3p (I suspect anything under 3p will be taken quickly) but if you believe in the story is 10% in either direction a major concern? Bottom line is, this project will either happen, or it won’t (either 1p or many multiples of today’s price) If the BoD pull this off (and I was impressed with their language and bullishness during the the presentation) whether you are in at 2.9p, 3.5p or 4p is almost irrelevant. I expect news before December (again based on presentation) so I have double my holding and averaged down recently (still significantly higher average price than todays price by the way) and will now wait it out, come what may.

This is a strong buy down here imo.

Good luck

This was posted yesterday by PSB123, and was unfortunately largely overlooked due to other threads. It is however hugely important and could be one of many catalysts that starts a serious re-rate from here. News on this could drop at any point and will be huge for the company.
=====================================

Understandably everyone is very excited about the demerger and the Covid trials right now (so am I, I see both as huge value creating inflection points) but the expected response from the FDA on approval for a phase 2 trial of Foralumab nasally administered is due any day now with the trial expected to start imminently and this doesn’t seem to be being mentioned at all. To quote from the half year results RNS:

‘Protocol for Phase 2 nasal clinical trial is finalized. The briefing package and protocol was submitted to FDA on July 22, 2020 requesting type C meeting and FDA response expected by mid October, 2020. The trial is anticipated to begin in Q4 2020.’

The simple answer to your question Swervington, is “research”. Anybody, and I mean anybody, that’s prepared to do more than 5 minutes research on Tiziana can quite easily see the investment case here. Your short term view (and I don’t mean this condescendingly) is typical of a traders approach.
As someone said earlier in this thread, the share price has risen 35% in little over 3 weeks so had a potential “new investor” Done some research in September, they’d be sitting pretty. To say “why would someone new invest knowing they’re going to be losing money” is, quite frankly, ridiculous, particularly when you look at what is in the pipeline and what is happening within just the next 2-3 weeks.

Yes, volumes are low, yes, this is being manipulated, yes, there is a Bot working the Nasdaq, and yes, it’s volatile, but there are very good reasons for all of those things, namely there are very few shares in free float and those “working” this are doing so because they’ve done their research (just like institutional investors did before they invested $57m at £2 a share) and it’ll be worth the effort.

People need to look at the bigger picture here, and, dare I say, look beyond StemPrintER. The short to medium term (3-6 months) news flow is staggering, and all being well, will produce massive upside/inflection points for anyone who takes time to understand the business. If people can’t see what’s under their noses with this company, then quite frankly, they deserve to miss out.

The 5 NDA’s currently in place tell me Tiziana will most probably NOT exist this time next year.

If I was the BoD, I’d be keeping everything non AccuStem related under wraps until Record Date.

Accepted Gooner.

GL

D-Gee, if you are buying on T+2 you need to buy them on 27th so they clear onto the Tiziana share register by 30th.
10 trading days to go!

Goodness me Gooner, what age ARE you? I have to say, I’ve seldom seen anyone on these BB’s post as many pointless, childish and cringeworthy posts as you do.
Grow up man, and if you’ve nothing relevant to say, just say nothing. You’re embarrassing yourself.

It’s the “inhalation delivery” patent we are still waiting on, as per the RNS on 24th August.

Apologies. Obviously that patent has already been granted, so numbers relating to this will be huge.

This is well worth another listen (or a first listen/watch if you’ve not seen it before).

Some of the drugs mentioned by Dr Shailu in this Clip and what this patent will cover are mind blowing. The numbers will be off the scale if we secure this patent.

https://www.proactiveinvestors.co.uk/companies/news/922922/tiziana-life-sciences-to-fast-track-development-of-its-coronavirus-antibody--inhalation-technology-922922.html

Thanks Goofy. That’s pretty much what I expected, and on a par with the rest of your posts.

That’s twice in a week this has gone into auction at 4.25pm and not come out before market close.
Any ideas why?

Bot just been turned on. Let’s see where it takes us today.

We’ll find out in 5 mins. It’s all about the Bot. On or Off, Buying or Selling. It will dictate direction, as always imo.

Looks like broker confirmation of 1 for 1 AccuStem shares is having a positive impact today. It hadn’t crossed my mind that people saw this as a particular issue, but maybe it was.
Hopefully an uplift in volume this afternoon will see us back towards £2.